Showing 25 to 36 of 215 results
Trump to Meet Putin in Alaska; Prasad Returns to FDA
President Trump announced a meeting with Vladimir Putin in Alaska on August 15, 2025, and Dr. Vinay Prasad is returning to his FDA position after a two-week absence following controversy.
Trump to Meet Putin in Alaska; Prasad Returns to FDA
President Trump announced a meeting with Vladimir Putin in Alaska on August 15, 2025, and Dr. Vinay Prasad is returning to his FDA position after a two-week absence following controversy.
Progress
48% Bias Score
FDA Official Returns After Resignation Amid Political Pressure
Dr. Vinay Prasad, FDA's Center for Biologics Evaluation and Research director, resigned in late July under White House pressure and attacks from Laura Loomer, but returned to his position on Saturday, prompting further criticism and threats of continued exposure from Loomer.
FDA Official Returns After Resignation Amid Political Pressure
Dr. Vinay Prasad, FDA's Center for Biologics Evaluation and Research director, resigned in late July under White House pressure and attacks from Laura Loomer, but returned to his position on Saturday, prompting further criticism and threats of continued exposure from Loomer.
Progress
56% Bias Score
FDA May Not Renew Pfizer's Covid-19 Vaccine for Young Children, Creating Potential Shortage
The US Food and Drug Administration (FDA) may not renew Pfizer's Covid-19 vaccine for children under five this fall, creating a potential vaccine shortage as Moderna's vaccine is only approved for children with pre-existing health conditions; this impacts the already low vaccination rates among this...
FDA May Not Renew Pfizer's Covid-19 Vaccine for Young Children, Creating Potential Shortage
The US Food and Drug Administration (FDA) may not renew Pfizer's Covid-19 vaccine for children under five this fall, creating a potential vaccine shortage as Moderna's vaccine is only approved for children with pre-existing health conditions; this impacts the already low vaccination rates among this...
Progress
40% Bias Score
U.S. States Crack Down on Food Additives Amidst Consumer Pressure and Political Shift
Across the U.S., dozens of states proposed bills in 2024 to limit synthetic food colorings and chemical additives, spurred by consumer pressure and a surprising political shift, with Arizona and Utah banning such dyes in school meals and Texas requiring warning labels for 44 additives.
U.S. States Crack Down on Food Additives Amidst Consumer Pressure and Political Shift
Across the U.S., dozens of states proposed bills in 2024 to limit synthetic food colorings and chemical additives, spurred by consumer pressure and a surprising political shift, with Arizona and Utah banning such dyes in school meals and Texas requiring warning labels for 44 additives.
Progress
40% Bias Score
FDA Chief Medical Officer Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, following a recent FDA reversal on Sarepta's Elevidys drug shipments.
FDA Chief Medical Officer Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, following a recent FDA reversal on Sarepta's Elevidys drug shipments.
Progress
44% Bias Score
FDA Recommends Ban on Kratom Byproduct 7-OH Amidst Overdose Concerns
The FDA recommends banning 7-hydroxymitragynine (7-OH), a concentrated kratom byproduct with morphine-like effects, due to a rise in overdoses and unregulated sales at gas stations and vape shops, posing significant public health risks.
FDA Recommends Ban on Kratom Byproduct 7-OH Amidst Overdose Concerns
The FDA recommends banning 7-hydroxymitragynine (7-OH), a concentrated kratom byproduct with morphine-like effects, due to a rise in overdoses and unregulated sales at gas stations and vape shops, posing significant public health risks.
Progress
56% Bias Score
FDA Director Prasad Resigns, Then Returns Amidst Controversy
Vinay Prasad, the FDA's Center for Biologics Evaluation and Research director, resigned on July 30th following criticism of the agency's handling of a gene therapy linked to patient deaths and attacks from Laura Loomer, but returned to his position on August 10th at the FDA's request.
FDA Director Prasad Resigns, Then Returns Amidst Controversy
Vinay Prasad, the FDA's Center for Biologics Evaluation and Research director, resigned on July 30th following criticism of the agency's handling of a gene therapy linked to patient deaths and attacks from Laura Loomer, but returned to his position on August 10th at the FDA's request.
Progress
40% Bias Score
FDA's Prasad Resumes Role After Resignation Amid Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned in late July amid White House pressure and criticism from Laura Loomer but has since returned to his position at the agency's request.
FDA's Prasad Resumes Role After Resignation Amid Political Pressure
Dr. Vinay Prasad, the FDA's chief medical and scientific officer, resigned in late July amid White House pressure and criticism from Laura Loomer but has since returned to his position at the agency's request.
Progress
56% Bias Score
Apeel Reveal Act Mandates Labeling of Produce Coatings
Rep. Stutzman's Apeel Reveal Act (HR 4737) mandates labeling of shelf-life-extending coatings on fruits and vegetables, impacting consumer choice and promoting transparency in the food industry; Apeel Sciences, a leading producer, supports the bill.
Apeel Reveal Act Mandates Labeling of Produce Coatings
Rep. Stutzman's Apeel Reveal Act (HR 4737) mandates labeling of shelf-life-extending coatings on fruits and vegetables, impacting consumer choice and promoting transparency in the food industry; Apeel Sciences, a leading producer, supports the bill.
Progress
40% Bias Score
Senate Confirms New CDC Director; Top FDA Official Resigns
Dr. Susan Monari was confirmed as the new CDC director on Tuesday after a 52-47 Senate vote, marking the first time Senate confirmation was required. Simultaneously, Dr. Vinay Prasad, a high-ranking FDA official and vocal critic of the administration's COVID-19 response, resigned from his position.
Senate Confirms New CDC Director; Top FDA Official Resigns
Dr. Susan Monari was confirmed as the new CDC director on Tuesday after a 52-47 Senate vote, marking the first time Senate confirmation was required. Simultaneously, Dr. Vinay Prasad, a high-ranking FDA official and vocal critic of the administration's COVID-19 response, resigned from his position.
Progress
36% Bias Score
FDA Official Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's head of the Center for Biologics Evaluation and Research, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, who accused him of being a "progressive leftist saboteur".
FDA Official Resigns Amidst Political Pressure
Dr. Vinay Prasad, the FDA's head of the Center for Biologics Evaluation and Research, resigned after less than three months due to White House pressure and public criticism from right-wing activist Laura Loomer, who accused him of being a "progressive leftist saboteur".
Progress
60% Bias Score
Sarepta Stock Surges After FDA Lifts Hold on Elevidys
Following the FDA's decision to lift the clinical hold on its Elevidys drug, Sarepta Therapeutics' stock price rose to approximately $19 in extended trading, driven by increased revenue potential and a company restructuring plan aiming for $400 million in annual cost savings by 2026.
Sarepta Stock Surges After FDA Lifts Hold on Elevidys
Following the FDA's decision to lift the clinical hold on its Elevidys drug, Sarepta Therapeutics' stock price rose to approximately $19 in extended trading, driven by increased revenue potential and a company restructuring plan aiming for $400 million in annual cost savings by 2026.
Progress
44% Bias Score
Showing 25 to 36 of 215 results